XRX.CN
XORTX Therapeutics Inc
Price:  
1.90 
CAD
Volume:  
111,400.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XRX.CN WACC - Weighted Average Cost of Capital

The WACC of XORTX Therapeutics Inc (XRX.CN) is 7.7%.

The Cost of Equity of XORTX Therapeutics Inc (XRX.CN) is 11.65%.
The Cost of Debt of XORTX Therapeutics Inc (XRX.CN) is 5.00%.

Range Selected
Cost of equity 10.00% - 13.30% 11.65%
Tax rate 26.50% - 26.50% 26.50%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.8% - 8.5% 7.7%
WACC

XRX.CN WACC calculation

Category Low High
Long-term bond rate 3.4% 3.9%
Equity market risk premium 4.7% 5.7%
Adjusted beta 1.39 1.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.00% 13.30%
Tax rate 26.50% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.8% 8.5%
Selected WACC 7.7%